Journal of Clinical Densitometry
Volume 11, Issue 1 , Pages 109-122 , January 2008

Dual-Energy X-Ray Absorptiometry Technical Issues: The 2007 ISCD Official Positions

  • Christine Simonelli

      Affiliations

    • HealthEast Osteoporosis Care, St. Paul, MN, USA
    • University of Minnesota, Minneapolis, MN, USA
    • Corresponding Author InformationAddress correspondence to: Christine Simonelli, MD, HealthEast Osteoporosis Care, 1875 Woodwinds Drive, Suite WL-30, Woodbury, MN 55127, USA.
    • Task Force Chair.
    • ,
  • Robert A. Adler

      Affiliations

    • Hunter Holmes McGuire VA Medical Center, Richmond VA, USA
    • Task Force Member.
    • ,
  • Glen M. Blake

      Affiliations

    • Guy's Hospital, London, UK
    • Task Force Member.
    • ,
  • JoAnn P. Caudill

      Affiliations

    • Erickson Retirement Communities, Catonsville, MD, USA
    • Task Force Member.
    • ,
  • Aliya Khan

      Affiliations

    • McMaster University, Oakville, Ontario, Canada
    • Task Force Member.
    • ,
  • Ed Leib

      Affiliations

    • University of Vermont, Burlington, VT, USA
    • Task Force Member.
    • ,
  • Michael Maricic

      Affiliations

    • Catalina Pointe Arthritis and Rheumatology Specialists, PC, Tucson, AZ, USA
    • Task Force Member.
    • ,
  • Jerilynn C. Prior

      Affiliations

    • University of British Columbia, Vancouver, British Columbia, Canada
    • Task Force Member.
    • ,
  • Sergio Ragi Eis

      Affiliations

    • CEDOES, Vitoria, ES, Brazil
    • Task Force Member.
    • ,
  • Cliff Rosen

      Affiliations

    • Maine Center For Osteoporosis Research & Education, Bangor, ME, USA
    • Task Force Member.
    • ,
  • David L. Kendler

      Affiliations

    • Prohealth Clinical Research Centre, Vancouver, British Columbia, Canada
    • PDC Task Force Liaison.

Received 5 December 2007 ,Accepted 5 December 2007.

References 

  1. Leslie WD, Adler RA, El-Hajj Fuleihan G, et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J Clin Densitom. 2006;9(1):22–30
  2. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16:222–228
  3. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int. 2005;16:737–742
  4. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375–382
  5. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19:893–899
  6. Smith MR, Lee WC, Brandman J, et al. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol. 2001;23(31):7897–7903
  7. Smith MR, Boyce SP, Myneur E, et al. Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol. 2006;175(1):136–139
  8. Greenspan SL, Coates P, Sereika SM, et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab. 2005;90(20):6410–6417
  9. Stoch SA, Parker RA, Chen L, et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab. 2001;86(6):2787–2791
  10. Eastell R. Pathogenesis of postmenopausal osteoporosis. In:  Favus MJ editors. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed.. Washington, DC: American Society for Bone and Mineral Research; 2003;p. 314–316
  11. Abrahamsen B, Nissen N, Hermann AP, et al. When should densitometry be repeated in healthy peri- and postmenopausal women? The Danish Osteoporosis Prevention Study. J Bone Miner Res. 2002;17:2061–2067
  12. Smeets-Goevaers CG, Lelusink GL, Papapoulos SE, et al. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study. Osteoporos Int. 1998;8(5):404–409
  13. Whyte MP. Genetic, developmental and dysplastic skeletal disorders. In:  Favus M,  Christakos S,  Gagel RF, et al. editor. Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed.. Washington, DC: American Society for Bone and Mineral Research; 2003;p. 449;[470–477]
  14. Cherian RA, Haddaway MJ, Davie MW, et al. Effect of Paget's disease of bone on areal lumbar spine bone mineral density measured by DXA, and density of cortical and trabecular bone measured by quantitative CT. Br J Radiol. 2000;73(871):720–726
  15. White MP. Misinterpretation of osteodensitometry with high bone density. J Clin Densitom. 2005;8(1):1–6
  16. Pappou IP, Firardi FP, Sandhu HS, et al. Discordantly high spinal bone mineral density values in patients with adult lumbar scoliosis. Spine. 2006;31(14):1614–1620
  17. Guglielmi G, Floriani I, Torri V, et al. Effect of spinal degenerative changes on volumetric bone mineral density of the central skeleton as measured by quantitative computed tomography. Acta Radiol. 2005;46(3):269–275
  18. Yu W, Gluer CC, Fuerst T, et al. Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int. 1995;57(3):169–174
  19. Writing Group for the ISCD Position Development Conference . Diagnosis of osteoporosis in men, premenopausal women and children. J Clin Densitom. 2004;7(1):17–26
  20. Kanis JA, Oden A, Johnell O, et al. 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteo Int, in press.
  21. Seeman E, Bianchi G, Khosla S, et al. Bone fragility in men—where are we?. Osteoporos Int. 2006;17:1577–1583
  22. Cummings SR, Cawthon PM, Ensrud KE, et al. for the Osteoporotic Fractures in Men (MrOS) and Study of Osteoporotic Fractures (SOF) Research Groups BMD and Risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res. 2006;21:1550–1556
  23. Melton LJ. Epidemiology of fractures. In:  Riggs BL,  Melton LJ editor. Osteoporosis: Etiology, Diagnosis and Management. 2nd ed.. Philadelphia: Lippincott-Raven press; 1995;p. 225–247
  24. Kanis JA, Johansson H, Oden A, et al. A family history of fracture and fracture risk. Bone. 2004;35:1029–1037
  25. Recker R, Lappe J, Davies K, et al. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res. 2000;15:1965–1973
  26. Randolph JF, Sowers M, Gold EB, et al. Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2003;88(4):1516–1522
  27. Chapurlat RD, Gamero P, Sornay-Rendy E, et al. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int. 2000;11(6):493–498
  28. Steinberg KK, Freni-Titulaer LW, DePuey EG, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989;69(3):533–539
  29. Rannevik G, Jeppsson S, Johnell O, et al. a longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21(2):103–113
  30. Sirola J, Kroger H, Honkanen R, et al. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?. Osteoporos Int. 2003;14(1):27–33
  31. Bergstrom I, Freyschuss B, Landgren BM. Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int. 2005;16(7):823–828
  32. Heinonen A, Oja P, Sioevanen H, et al. Effect of two training regimens on bone mineral density in healthy perimenopausal women: a randomized controlled trial. J Bone Miner Res. 1998;13(3):483–490
  33. Sirola J, Rikkonen T, Tuppurainen M, et al. Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study. Calcif Tissue Int. 2006;78(4):218–226
  34. Bainbridge KE, Sowers M, Lin X, et al. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int. 2004;15(6):439–446
  35. Holm K, Dan A, Wilbur J, et al. A longitudinal study of bone density in midlife women. Health Care Women Int. 2002;23(6–7):678–691
  36. Cooper L, Clifton-Bligh PB, Nery ML, et al. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr. 2003;77(5):1324–1329
  37. Patel R, Blake GM, Fogelman I. Peripheral and central measurement of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis. Calcif Tissue Int. 2007;80(2):89–96
  38. Van der Voort DJ, Geusens PP, Dinant GJ. Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int. 2001;12(8):630–638
  39. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286(22):2815–2822
  40. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1993;118:657–665
  41. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315:841–846
  42. Ebeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 1996;81(9):3355–3371
  43. Iki M, Morita A, Ikeda Y, et al. for the JPOS Study Group Biochemical markers of bone turnover may predict progression to osteoporosis in osteopenic women: the JPOS Cohort Study. J Bone Miner Metab. 2007;25(2):122–129
  44. Mallmin H, Ljunghall S, Persson I, et al. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years follow-up. Calcif Tissue Int. 1993;52:269–272
  45. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721–727
  46. Aloia JF, Cohn SH, Vaswani A, et al. Risk factors for postmenopausal osteoporosis. Am J Med. 1985;78:95–100
  47. Wasnich RD, Davis JW, Ross PD. Spine fracture risk is predicted by non-spine fractures. Osteoporos Int. 1994;4:1–5
  48. Black DM, Arden NK, Palermo L, et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14:821–828
  49. Honkanen M, Tuppurainen M, Kroger H, et al. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int. 1997;60(4):327–331
  50. Barrett-Connor E, Slone S, Greendale G, et al. The postmenopausal estrogen/progestin intervention study: primary outcomes in adherent women. Maturitas. 1997;27(3):261–274
  51. Hosking D, Chilvers CED, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med. 1998;338:485–492
  52. Ravn P, Weiss SR, Rodriguez-Portales JA, et al. Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group. J Clin Endocrinol Metab. 2000;85:1492–1497
  53. Mortensen L, Charles P, Bekker PJ, et al. Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab. 1998;83:396–402
  54. Jolly EE, Bjarnason NH, Neven P, et al. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Menopause. 2003;10:337–344
  55. McClung MR, Wasnich RD, Recker R, et al. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis. J Bone Miner Res. 2004;19:11–18
  56. Siris ES, Brenneman SK, Barrett-Connor E, et al. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2006;17(4):565–574
  57. Siris ES, Brenneman SK, Miller PD, et al. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50–64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res. 2004;19(8):1215–1220
  58. NIH Consensus Development Conference Statement, March 2000: Osteoporosis Prevention, Diagnosis and Therapy. Available at: http://consensus.nih.gov/2000/2000Osteoporosis111html.htm.
  59. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. J Bone Miner Res. 2001;16:S194
  60. Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at mid-life: ovarian and chronological aging. J Clin Endocrinol Metab. 2007;92(3):895–901
  61. WHO . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. [Technical Report Series No. 843] Geneva, Switzerland: WHO; 1994;
  62. Binkley N, Bilezikian JP, Kendler DL, et al. International Society for Clinical Densitometry Official positions of the International Society and Executive summary of the 2005 Position Development Conference. J Clin Densitom. 2006;9(1):4–14
  63. National Osteoporosis Foundation . Physician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2003;Available at: www.nof.org
  64. Kocher MS, Kasser JR. Osteopetrosis. Am J Orthop. 2003;32(5):222–228
  65. Brown JP, Josse RG. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J. 2002;167(10 Suppl):S1–S34
  66. Ott S. Osteoporosis and bone physiology. Available at: http://courses.washington.edu/bonephys/opbmd.html2007;[Used with permission]
  67. http://en.wikipedia.org/wiki/Carl_Friedrich_Gauss
  68. http://en.wikipedia.org/wiki/Normal_distribution
  69. Bonnick SL, Lewis LA. Bone densitometry for technologists. 2nd ed.. New Jersey: Humana Press; 2006;
  70. Blake GM, Fogelman I. The role of DXA scanning in the diagnosis and treatment of osteoporosis. J Clin Densitom. 2007;10:102–110
  71. Melton LJ, Atkinson EJ, O'Fallon WM, et al. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993;10:1227–1233
  72. Krege JH, Miller PD, Lenchik L, et al. New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status. J Clin Densitom. 2006;9(2):144–149[Epub May 2, 2006]
  73. Smith JA, Vento JA, Spencer RP, et al. Aortic calcification contributing to bone densitometry measurement. J Clin Densitom. 1999;2(2):181–183
  74. Blake GM. Unpublished reference data for 7000 UK women.
  75. Faulkner KG, Von Stetton E, Miller P. A list of device specific thresholds for the clinical interpretation of peripheral X-ray absorptiometry examinations. Osteoporos Int. 1999;16:2149–2156
  76. Blake GM, Chinn DJ, Steel SA, et al. A list of device specific thresholds for the clinical interpretation of peripheral X-ray absorptiometry examinations. Osteoporos Int. 2005;16:2149–2156
  77. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8:468–489
  78. Chavassieux P, Seeman E, Delmas PD. Insights into material and structural basis of bone fragility from diseases associated with fractures. Endocr Rev. 2007;28(2):151–164
  79. Shapiro F. Osteopetrosis: current clinical considerations. Clin Orthop. 1993;33–44
  80. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351(27):2839–2849
  81. Simonelli C, Sinner PJ, Schoeller, MC. Prevalence of high bone mineral density T-scores in a community population. Poster presentation T455 ASBMR, 2007; Abstract JBMR 2007.
  82. Whyte MP. Skeletal disorders characterized by osteosclerosis or hyperostosis. In:  Avioli LV,  Krane SM editor. Metabolic Bone Disease and Clinically Related Disorders. 3rd ed.. San Diego, CA: Academic Press; 1998;p. 697–738
  83. Rand T, Seidl G, Kainberger F, et al. Impact of spinal degenerative changes on the evaluation of bone mineral density with dual energy X-ray absorptiometry (DXA). Calcif Tissue Int. 1997;60:430–433
  84. Liu G, Peacock M, Eilam O, et al. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int. 1997;7:564–569
  85. Peel NFA, Johnson A, Barrington NA, et al. Impact of anomalous vertebral segmentation of measurements of bone mineral density. J Bone Miner Res. 1993;8:719–723
  86. Bonnick SL. Bone Densitometry in Clinical Practice. 2nd ed.. New Jersey: Humana Press; 2004;37
  87. Davis JW, Grove JS, Wasnich RD, et al. Spatial relationships between prevalent and incident fractures. Bone. 1999;24:261–264
  88. Lang TF, Guglielmi G, van Kuijk C, et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone. 2002;30(1):247–250
  89. Dugan LO, Dugan DA, Dugan WM. Back Pain: the primrose path—a case report. Indiana Med. 1990;83(2):114–116
  90. Nevitt MC, Lane NE, Scott JC, et al. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum. 1995;38:907–916
  91. Lu PW, Briody JN, Ogle GD, et al. Bone mineral density of total body, spine and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res. 1994;9:1451–1458
  92. Frye MA, Melton LJ, Bryant SC, et al. Osteoporosis and calcification of the aorta. J Bone Miner Res. 1992;19:185–194
  93. Frohn J, Wilken T, Falk S, et al. Effect of aortic sclerosis on bone mineral measurements by dual-photon absorptiometry. J Nucl Med. 1990;32:259–262
  94. Orwoll ES, Oviatt SK, Mann T. Effect of aortic sclerosis on bone mineral measurements by dual-photon absorptiometry. J Nucl Med. 1990;32:259–262
  95. Drinka PJ, DeSmet AA, Bauwens SF, et al. The effect of overlying calcification on lumbar bone densitometry. Calcif tissue Int. 1992;50:507–510
  96. Shankar S, Hosking DJ. Biochemical assessment of Paget's Disease of Bone. J Bone Miner Res. 2006;21(Suppl 2):22–27
  97. Laroche M, Delpech B, Bernard J, et al. Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment. Calcif Tissue Int. 1999;65(3):188–191
  98. Henriksen K, Gram J, Hoegh-Andersen P, et al. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T2531 mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol. 2005;167(5):1341–1348
  99. Schilling AF, Mulhausen C, Lehmann W, et al. High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K. Osteoporos Int. 2007;18(5):659–669
  100. Nora EH, Kennel KA, Christian RC. Traumatic fracture in a healthy man: benign or pathologic?. Endocr Pract. 2006;12(5):552–558
  101. Kurland ES, Schulman RC, Zerwekh JE, et al. Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res. 2007;22(1):163–170
  102. Boivin G, Chavassieux P, Chapuy MC, et al. Histomorphotmetric profile of bone fluorosis induced by prolonged ingestion of Vichy Sanit-Yorre water. Comparison with bone fluorine levels. Pathol Biol (Paris). 1986;34(1):33–39
  103. Tamer MN, Kale KB, Arsian C, et al. Osteosclerosis due to endemic fluorosis. Sci Total Environ. 2007;373(1):43–48[Epub Dec 19, 2006]
  104. Bouletreau PH, Bost M, Fontanges E, et al. Fluoride exposure and bone status in patients with chronic intestinal failure who are receiving home parenteral nutrition. Am J Clin Nutr. 2006;83(6):1429–1437
  105. Frame B, Honasoge M, Kottamasu SR. Osteosclerosis, Hyperostosis and Related Disorders. New York, NY: Elsevier; 1987;
  106. Whyte MP. High bone mass disease. In:  Kleerekoper M,  Sirus E,  McClung M editor. The Bone and Mineral Manual: A Practical Guide. 2nd ed.. San Diego, CA: Academic Press; 2004;
  107. Albers-Schonberg H. Rontgenbilder einer siltenen, Knochenerkrankung. Munch Med Wochenschr. 1904;51:365
  108. Resnick D, Niwayama G. Diagnosis of Bone and Joint Disorders. 3rd ed.. Philadelphia: WB Saunders; 1995;
  109. Johnston CC, Lavy N, Lord T, et al. Osteopetrosis: a clinical, genetic, metabolic and morphologic study of the dominantly inherited, benign form. Medicine. 1968;47:149–167
  110. Bollerslev J. Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical and hormonal aspects. Endocr Rev. 1989;10:45–67
  111. Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri E. Osteopetrosis in children: a report of 26 cases. J Pediatr. 1977;91:43–47
  112. Whyte MP. Skeletal disorders characterized by osteoclerosis or hyperostosis. In:  Avioli LV,  Krane SM editor. Metabolic Bone Disease. 2nd ed.. San Diego: Academic Press; 1997;p. 697–738
  113. Whyte MP. Sclerosing bone disorders. In:  Favus Murray J editors. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 1999;
  114. Khosla S, Hassoun AAK, Baker BK, et al. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis: a means to increase bone mass in adults?. J Clin Invest. 1998;101:2165–2173
  115. Koay MA, Woon PY, Zhang Y, et al. Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res. 2004;19(10):1619–1627
  116. Nelson RL, Turyk M, Kim J, et al. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer. 2002;12(1):22
  117. Nelson RL, Turky M, Kim J, et al. Bone mineral density and subsequent risk of prostate cancer in the NHANES I follow-up. IARC Sci Publ. 2002;156:319–321
  118. Crandall C, Palla S, Reboussin BA, et al. Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res. 2005;7(6):R922–R928
  119. Ganry O, Tramier B, Fardellone P, et al. High bone-mass density as a marker for breast cancer in post-menopausal women. Breast. 2001;10:313–317
  120. Zmuda M, Cauley JA, Ljung BM, et al. for the Study of Osteoporotic Fractures Research Group Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst. 2001;93(12):930–936
  121. Nguyen TV, Center JR, Eisman JA. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas. 2000;36:27–34
  122. Kerlikowske K, Shepherd J, Creasman J, et al. Are breast density and bone mineral density independent risk factors for breast cancer?. J Natl Cancer Inst. 2005;97(5):368–374
  123. Vandevord PJ, Wooley PH, Darga LL, et al. Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat. 2006;100(1):103–107
  124. Simberg N, Tiitinen A, Silfvast A, et al. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement. J Clin Endocrinol Metab. 1996;81(2):646–651

PII: S1094-6950(07)00257-0

doi: 10.1016/j.jocd.2007.12.009

Journal of Clinical Densitometry
Volume 11, Issue 1 , Pages 109-122 , January 2008

Article Tools

* Image Usage & Resolution